The most common primary liver cancer is hepatocellular carcinoma (HCC), and its mortality
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …

The past decades have witnessed increased use of biomarkers in disease management. A
biomarker is any characteristic that can be objectively measured and evaluated as an …

Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death
worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and …

Hepatocellular carcinoma (HCC) is a significant cause of mortality in patients with chronic
liver disease around the world. Development of biomarkers for early HCC detection is a …

Hepatocellular carcinoma (HCC) is the most frequent malignant tumour of the liver. HCC
prognosis is dependent on the determination of the tumour stage by conventional imaging …

Introduction: Current methods for HCC diagnosis have not an optimal diagnostic accuracy.
The detection of more than one biomarker seems to improve their individual performance …

Hepatocellular carcinoma (HCC) is among the world's third most lethal cancers. In resource-
limited settings (RLS), up to 70% of HCCs are diagnosed with limited curative treatments at …

Results Serum tumor markers, such as alpha-fetoprotein (AFP) and des-gammacarboxy
prothrombin (DCP) are commonly used for the surveillance, but their roles have been …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide. If diagnosed early, curative treatment options such as surgical resection, loco …

Hepatocellular carcinoma (HCC) is the most common liver malignancy and a leading cause
of cancer-related mortality worldwide. Accurate detection and differential diagnosis of early …